cgoncology_cover.jpg
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024
April 24, 2024 10:00 ET | CG Oncology Inc.
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024
immunocore-logo-2018
Immunocore announces upcoming presentation and posters at ASCO 2024
April 24, 2024 10:00 ET | Immunocore Holdings plc
Immunocore announces upcoming presentation and posters at ASCO 2024 Phase 1 expansion data in immune checkpoints pre-treated cutaneous melanoma for brenetafusp (IMC-F106C targeting PRAME) to be...
MacroGenics-Logo-(transparent-background).png
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
March 07, 2024 16:01 ET | MacroGenics, Inc.
Presentation of preliminary data from TAMARACK Phase 2 study of vobra duo in mCRPC patients expected at ASCO 2024Initiation of Phase 1 study of MGC026, MacroGenics' first topoisomerase I...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen To Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer on February 13, 2024
February 05, 2024 07:00 ET | FibroGen, Inc.
SAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced it will host Part I of a virtual KOL investor event series on Tuesday, February 13, 2024 at 10:30 AM...
Adagene_Logo_GNW.png
Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
January 16, 2024 17:01 ET | Adagene Inc.
- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose expansion showed clinical benefit including confirmed responses at higher, more frequent and...
Graphic 1
Goliath Discovers Extensive Mineralization in Multiple Outcrops Over 500 Meters on the Icefields That Remains Wide Open - Golden Triangle, B.C.
August 28, 2023 07:08 ET | Goliath Resources Limited
2023 Icefields Exploration Highlights: Three (3) new zones consisting of sulphide-rich breccia, stockwork and veins in shear zones have been discovered on the icefields claim blocks of the Golddigger...
Infographic 1
CORRECTION -- Goliath Commences Drilling at New Gold-Copper Porphyry and High-Grade Gold Breccia Targets at Its Lucky Strike Property Near Terrace, British Columbia
August 21, 2023 08:48 ET | Goliath Resources Limited
TORONTO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (Frankfurt: B4IF), please note that a...
Infographic 1
Goliath Commences Drilling at New Gold-Copper Porphyry and High-Grade Gold Breccia Targets at Its Lucky Strike Property Near Terrace, British Columbia
August 21, 2023 07:08 ET | Goliath Resources Limited
BULLSEYE GOLD-COPPER PORPHYRY – ~1,000 Metres Diamond Drilling, Highlights: The Bullseye porphyry is a drill ready target that shows all the right components for an extensive gold-copper porphyry...
Infographic 1
Goliath Intercepts 23 Meters* of 21.08 g/t AuEq, Including 14 Meters* of 33.75 g/t AuEq at Surebet Golden Gate Feeder Zone, Golden Triangle, B.C
August 15, 2023 10:18 ET | Goliath Resources Limited
Drill Highlights: GD-23-157 is a 485 gram x meter AuEq hole (15.59 troy ounces gram meter AuEq) collared from Cliff Pad within the Golden Gate Feeder Zone that intercepted Visible Gold mineralization...
Infographic 1
Second Visible Gold Hole Drilled From Cliff Pad at Goliath's Surebet Golden Gate Feeder Zone and 19.87 Meters* of Significant Mineralization, Golden Triangle, B.C.
July 24, 2023 07:00 ET | Goliath Resources Limited
Drill Hole GD-23-135 Highlights: Visible Gold has been intercepted at 60.91 meters within the Surebet Golden Gate Feeder Zone and is the second hole drilled from Cliff Pad in 2023 to contain...